aMino]Methyl]-2-[[[[(3R](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE432000-R_f745c818-9ecf-4c04-a9b8-67d22bc6f145.svg?v=1700581716)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
1-[[[(4-Aminophenyl)sulfonyl](2-Methylpropyl)aMino]Methyl]-2-[[[[(3R
28 / / Ciprofibrate Acyl-O-β-D Glucuronide / Ciprofibrate Glucuronide
MUC5AC(2449-2464)-Tn(2451
/ RPB1 CTD(1615-1621-Lys)-GlcNAc(1619) / Synthetic RPB1 at C-terminal domain(CTD) glycopeptide
α-L-Rha-Bu-CO2H
PE432000: β-Gal-PEG3-Acid Pack Size:25 mg 1-[[[(4-Aminophenyl)sulfonyl](2-Methylpropyl)aMino]Methyl]-2-[[[[(3RC13H24O10 340. 32 A D galactose ligand equipped with a terminal carboxylic acid through a hydrophilic PEG3 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound provides a anomeric galactose building block for glycoconjugate synthesis, glycomimetic research, and the construction of probes
US$ 149.07
US$ 119.86
